iTeos Therapeutics Inc

General ticker "ITOS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $347.6M

iTeos Therapeutics Inc follows the US Stock Market performance with the rate: 1.1%.

Estimated limits based on current volatility of 2.9%: low 7.10$, high 7.53$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [6.45$, 13.69$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.70$, 13.82$]

Financial Metrics affecting the ITOS estimates:

  • Negative: Non-GAAP EPS, $ of -3.15 <= 0.10
  • Negative: Operating profit margin, % of -92.31 <= 1.03
  • Negative: Operating cash flow per share per price, % of -22.05 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Investing cash flow per share, $ of 2.03 > -0.12

Similar symbols

Short-term ITOS quotes

Long-term ITOS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $344.77MM $267.63MM $12.60MM
Operating Expenses $99.87MM $141.31MM $163.70MM
Operating Income $244.90MM $126.32MM $-151.10MM
Non-Operating Income $11.56MM $22.41MM $42.07MM
R&D Expense $59.37MM $97.36MM $113.30MM
Income(Loss) $256.46MM $148.74MM $-109.03MM
Taxes $41.94MM $52.08MM $3.61MM
Profit(Loss) $214.52MM $96.65MM $-112.64MM
Stockholders Equity $552.82MM $663.33MM $575.23MM
Inventory $10.09MM $0.00MM $0.00MM
Assets $884.71MM $754.99MM $667.59MM
Operating Cash Flow $513.14MM $-111.19MM $-103.76MM
Capital expenditure $1.18MM $0.94MM $2.97MM
Investing Cash Flow $-1.24MM $-446.06MM $72.66MM
Financing Cash Flow $3.66MM $1.98MM $1.11MM
Earnings Per Share* $6.10 $2.72 $-3.15

* EPS are Split Adjusted, recent splits may be reflected with a delay.